Arsanis' Series A Round

Arsanis raised a round of funding on February 28, 2011.

Arsanis is a clinical-stage company creating precision monoclonal antibodies for the prevention and treatment of serious bacterial infections not effectively controlled by currently available treatmen…

Articles about Arsanis' Series A Round: